The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.

Journal of Neuro-oncology
Mateo ZiuJeffrey J Olson

Abstract

These recommendations apply to adult patients diagnosed with newly diagnosed glioblastoma. QUESTION 1 : In adult patients (aged 65 and under) with newly diagnosed glioblastoma, is the addition of radiation therapy (RT) more beneficial than management without RT in improving survival? Level I: Radiation therapy (RT) is recommended for the treatment of newly diagnosed malignant glioblastoma in adults. QUESTION 2 : In adult patients (aged 65 and under) with newly diagnosed glioblastoma, is the RT regimen of 60 Gy given in 2 Gy daily fractions more beneficial than alternative regimens in providing survival benefit while minimizing toxicity? Level I: Treatment schemes should include dosage of up to 60 Gy given in 2 Gy daily fractions that includes the enhancing area. QUESTION 3 : In adult patients (aged 65 and under) with newly diagnosed glioblastoma, is a tailored target volume superior to regional RT for reduction of radiation-induced toxicity while maintaining efficacy? Level II: It is recommended that radiation therapy planning include 1-2 cm margin around the radiographically T1 weighted contrast-enhancing tumor volume or the T2 weighted abnormality on MRI. Level III: Recalculation of the radiation volume during RT treatment ma...Continue Reading

References

Feb 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T E GoffmanE Glatstein
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W RoaP Forsyth
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
May 12, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Corrie A M MarijnenEd M Noordijk
Jun 6, 2006·International Journal of Radiation Oncology, Biology, Physics·Robert CardinaleMinesh Mehta
Oct 31, 2007·International Journal of Radiation Oncology, Biology, Physics·Stephanie E CombsDaniela Schulz-Ertner
Aug 21, 2008·Journal of Neuro-oncology·John BuattiJeffrey J Olson
Dec 3, 2008·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·A IdbaihJ-J Mazeron
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Deborah T BlumenthalBenjamin W Corn
Apr 20, 2010·International Journal of Radiation Oncology, Biology, Physics·Mark W McDonaldIan R Crocker
Jul 20, 2010·Journal of Neuro-oncology·Mizuhiko TerasakiMinoru Shigemori
Aug 3, 2010·International Journal of Radiation Oncology, Biology, Physics·Jacob ScottHsiang-Hsuan Michael Yu
Nov 9, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christina I TsienTheodore Lawrence
Nov 15, 2011·International Journal of Radiation Oncology, Biology, Physics·Giuseppe MinnitiRiccardo Maurizi Enrici
Jan 11, 2012·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·M NiyaziC Belka
Mar 27, 2012·International Journal of Radiation Oncology, Biology, Physics·Douglas B EinsteinRobert Maciunas
Apr 10, 2012·International Journal of Radiation Oncology, Biology, Physics·Krishna ReddyChanghu Chen
Aug 3, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Izaskun ValduviecoFrancesc Graus
Mar 7, 2013·International Journal of Radiation Oncology, Biology, Physics·Percy LeeJung Julie Kang
Apr 2, 2013·International Journal of Radiation Oncology, Biology, Physics·Linda ChenKristin Redmond
Apr 30, 2013·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·L FariselliA Salmaggi
May 7, 2013·International Journal of Radiation Oncology, Biology, Physics·Giuseppe MinnitiRiccardo Maurizi Enrici
Aug 21, 2013·Journal of Korean Medical Science·Tae Gyu Kim, Do Hoon Lim
Sep 27, 2014·International Journal of Radiation Oncology, Biology, Physics·Shahed N BadiyanJiayi Huang
Dec 3, 2014·International Journal of Radiation Oncology, Biology, Physics·Giuseppe MinnitiRiccardo Maurizi Enrici
Jan 15, 2015·International Journal of Radiation Oncology, Biology, Physics·Chad G RusthovenBrian D Kavanagh
Apr 7, 2015·International Journal of Radiation Oncology, Biology, Physics·Nils D ArvoldBrian M Alexander
Sep 24, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wilson RoaElena Fidarova
Oct 10, 2015·Journal of Neurosurgery·Ranjith BabuCory Adamson

❮ Previous
Next ❯

Citations

Jul 27, 2021·Frontiers in Oncology·Xanthene MilesJulie Bolcaen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.